DCDuncan Cole

Duncan Cole

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Duncan Cole has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Rare dISease Evaluation (RISE) study: a survey-based investigation of medical student experience and knowledge of rare disease in the UK

    by Helen Maginnis, Agata Oliwa, Melissa Classen, Alexandra Adams, Zainab Alani, Leah Brooksbank, Charlotte Mercer, Yasmin Nikookam, Madeline Pearson, Aung Min Saw, et al.

    Background: Rare diseases are a significant public health concern, with over 6,000 diseases identified with an estimated collective point prevalence of 5.6–6.9%. People living with rare disease face numerous challenges within healthcare including prolonged time to diagnosis and difficulties accessing specialist care, in part due to a substantial knowledge gap among healthcare professionals. This study aimed to investigate UK medical students’ self-assessed knowledge and awareness and objective knowledge of rare disease, as well as their experiences of undergraduate rare disease education. Methods: A cross-sectional online survey comprising 28 items was distributed to medical students at 35 General Medical Council-accredited medical schools. Descriptive and inferential statistical analyses were used to examine rare disease knowledge, awareness, educational experiences and their associations. Free-text responses were reviewed to identify recurring themes. Results: 253 responses were recorded from undergraduate and graduate-entry medical students. 126 responses from students at 27 medical schools were fully completed, permitting analysis. Respondents represented all years of medical study, although 79% were in years 1–4 or undertaking intercalation. Median self-assessed rare disease knowledge was 3/10 and the median objective knowledge score was 9/15. There was no consistent improvement in self-assessed knowledge, self-assessed awareness, or objective rare disease knowledge with progression through medical school. Greater clinical exposure to people living with rare disease and a personal connection to the rare disease community were associated with higher self-assessed knowledge and awareness but not higher objective knowledge scores. Over half of respondents had received some rare disease education; just one in five felt prepared to recognise or consider a rare disease in practice. Most students (73.8%) expressed interest in further education, with lectures identified as the preferred mode of delivery. Qualitative findings highlighted curriculum overload and the impracticality of learning detailed information about individual rare diseases. Conclusion: Important gaps in rare disease knowledge and preparedness for practice exist amongst UK medical students despite strong interest in further rare disease education. Clinical exposure alone may be insufficient to develop transferable rare disease knowledge, highlighting the potential value of educational approaches that combine experiential learning with structured educational support.

  • Open Access

    How Well Is Blood Phenylalanine Controlled in Maternal PKU in Europe? Results from 102 Pregnancies

    by Alex Pinto, Kirsten Ahring, Manuela Ferreira Almeida, Catherine Ashmore, Sarah Bailey, Amaya Bélanger-Quintana, Alberto Burlina, Duncan Cole, Clare Dale, Anne Daly, et al.

    Background/Objectives: In phenylketonuria (PKU), high blood phenylalanine (Phe) levels during pregnancy negatively influence foetal organogenesis and growth, leading to maternal PKU syndrome. Pregnancies must be carefully planned in order to maintain blood Phe levels ≤ 360 µmol/L pre-conception and throughout pregnancy. Our aim was to study metabolic control in PKU pregnancies across Europe. Methods: Eleven centres managing PKU participated. Data on blood Phe levels (µmol/L), natural protein intake (g/day), protein substitute intake (g/day) and maternal weight (kg) during pregnancy were collected retrospectively from dietetic records between 2012 and 2018. Results: In total, 84 female patients with PKU, accounting for 102 pregnancies (mean age: 30.4 ± 4.8 years), participated. Of these, 7 had hyperphenylalaninemia (HPA), 26 had mild PKU, 55 had classical PKU and 14 were unclassified. Sapropterin was prescribed in two pregnancies. Only 27% (28/102) of pregnancies successfully achieved consistent blood Phe levels ≤ 360 µmol/L for at least 2 weeks pre-conception. During pregnancy, 88% of blood Phe levels were ≤360 µmol/L, with a mean Phe of 229 ± 65 µmol/L. The mean number of blood Phe samples was 60 (1.5 per week) per pregnancy. In pre-pregnancy, over a mean of 2.9 years, only 35% of blood Phe levels were ≤360 µmol/L and 61% were <600 µmol/L. Post-pregnancy, over a mean of 2.8 years, 43% of Phe levels were <600 µmol/L with mean Phe 462 ± 226 µmol/L and 724 ± 230 µmol/L, respectively. 25% (25/102) had no levels performed post-pregnancy (mean of 2.8 ± 1.6 years) compared to 7% (7/102) pre-pregnancy (mean of 2.9 ± 1.5 years). Mean prescribed Phe intake pre-/during/post-pregnancy was 810 ± 721 vs. 787 ± 552 vs. 1110 ± 722 mg/day. Natural protein intake was 17 ± 15 vs. 17 ± 11 vs. 23 ± 15 g/day. Protein equivalent from protein substitute intake was 57 ± 21 vs. 66 ± 16 vs. 50 ± 23 g/day and total protein remained stable, 73 ± 14 vs. 83 ± 14 vs. 71 ± 19 g/day (1.1 ± 0.3 vs. 1.1 ± 0.4 vs. 1.0 ± 0.4 g/kg/day). Conclusions: Although a high level of metabolic control was maintained during pregnancy, fewer than 30% of pregnancies achieved constant Phe levels ≤ 360 µmol/L prior to conception, with minimal monitoring post-pregnancy. The long-term impact on the offspring remains unknown and requires further investigation.


  • Open Access

    Blood Phenylalanine Control in Paediatric and Adult Centres in the UK: Data from 2012–2018

    by Alex Pinto, Catherine Ashmore, Jane Ash, Barbara Cochrane, Duncan Cole, Sarah Bailey, Clare Dale, Anne Daly, Charlotte Dawson, Sharon Evans, et al.

    Background: Metabolic control in phenylketonuria (PKU) is known to deteriorate with age, but national-level data describing blood phenylalanine (Phe) control across the United Kingdom (UK) are limited. Objective: To characterise blood Phe control in individuals with PKU attending UK metabolic centres. Methods: Sixteen UK centres (nine paediatric, six adult, one mixed) retrospectively extracted blood Phe results collected between 2012 and 2018. Demographic, phenotypic and monitoring-related variables were analysed. Written consent for data collection was obtained from all patients or their caregivers. Results: Data were available for 871 individuals (55% female), of whom 744 (85%) were classified as follows: classical PKU, 75%, mild PKU, 22% and hyperphenylalaninaemia, 3%. Mean blood Phe concentrations were significantly higher in adults than children (491 ± 308 vs. 303 ± 199 µmol/L; p < 0.001), and the proportion of samples within target range declined steadily with age, from 78% in children < 2 years to 36% in adults ≥ 41 years. Individuals with classical PKU had higher mean Phe concentrations and lower target attainment than those with HPA (386 vs. 300 µmol/L; 61% vs. 78%; p < 0.001), while mild PKU and HPA showed comparable control. Females generally demonstrated better metabolic control than males. More frequent dried blood spot sampling for blood Phe was strongly associated with improved metabolic control: weekly (254 ± 175 µmol/L; 82% within target), fortnightly (319 ± 207 µmol/L; 70%), monthly (397 ± 231 µmol/L; 61%), and less than monthly (624 ± 349 µmol/L; 44%). Nearly half of the blood Phe samples (47%) with recorded timing were taken in a non-fasting state. Conclusions: Achieving lifelong metabolic stability on a Phe-restricted diet alone remains challenging. These national data highlight the need for broader therapeutic options to support individuals with PKU across the lifespan.

  • Open Access

    Explainable Machine Learning to Uncover Distinct Phenotypic Signatures of Hypertrophic Cardiomyopathy and Fabry Disease

    by Suraj Ramchand, Matthew Ploszajski, Avraj Virdi, Duncan Cole, Xianghua Xie

    Background: Fabry Disease (FD) is a rare metabolic condition, characterised by a wide range of symptoms and progressive deterioration of the heart, kidneys and nervous system. The condition often goes undiagnosed for between 3-10 years, with misdiagnoses during this period being common. A historically common misdiagnosis for FD is Hypertrophic Cardiomyopathy (HCM). This condition mimics the cardiac symptoms of FD, although it does not share the same genetic pathology. Machine learning (ML) is a subfield of artificial intelligence that has shown promise in identifying rare diseases, including FD. This study builds on previous research to identify FD in routine clinical test data and provide a robust explainability framework. Methods: Cardiac test data (ECG, Holter and Echo) was extracted for 100 HCM and 49 FD patients. Stratified repeated K-fold cross-validation procedure was employed to select the optimum ML classifier. Following this, we explored a range of ML models and ensembling approaches. Each tuned classifier was trained on this data to identify differences between the experimental groups. Feature importance, SHAP values and partial dependence plots were generated to explain the model's decision-making process. Results: Following cross-validation, the Extreme Gradient Boosting (XGB) classifier emerged as the most reliable classification algorithm (AUC and F1 score: 0.92). T-axis, gender and age were revealed as consistently being the primary features used by the model for classification predictions. Conclusion: XGB proved to be a reliable classifier between FD and HCM for this dataset. The most important features largely aligned with established clinical approaches to differentiating phenotypes between HCM and FD. Future work should aim to compare the performance of this model against expert clinicians to compare these methods to the human state of the art.


  • Open Access

    Sparking interest in public health amongst future doctors to tackle our NHS sustainability crisis

    by Hannah Beetham, Duncan Cole, Rhiannon Phillips, Fiona Wood, Hannah Broughton, Cono Ariti, Behrooz Behbod

    This article was migrated. The article was marked as recommended. The new NHS 'Long Term Plan' has a particular focus on the public health issues of disease prevention and reducing health inequalities. However, medical students often perceive public health as abstract and irrelevant to clinical practice. We believe students need to be encouraged to appreciate wider public health issues and ultimately be able to apply clinical and public health tools to achieve change for patients and populations. Our aim is for all medical graduates to be able to apply public health and evidence-based principles to their chosen specialties. In the undergraduate curriculum, we hope to extend problem-, case-, and simulation-based learning into public health education, emphasise the context around statistics and epidemiology teaching, and make the teaching more relevant, tangible and enjoyable. Intercalated BSc students will gain an interdisciplinary perspective by joining Master of Public Health (MPH) students to learn about the prevention and control of disease and the promotion of health and wellbeing. They will also have opportunities to join the new Health Intelligence Team (H.I.T.), on a voluntary reserve list to support Public Health Wales in the event of real investigations. We will evaluate these strategies, and we hope that medical educators worldwide will share their experience of innovative approaches to public health and evidence-based medicine teaching in response to this article, so that public health teaching may be improved.

  • Open Access

    Using social media to support small group learning

    by Duncan Cole, Emma Rengasamy, Shafqat Batchelor, Charles Pope, Stephen Riley, Anne Marie Cunningham

    Medical curricula are increasingly using small group learning and less didactic lecture-based teaching. This creates new challenges and opportunities in how students are best supported with information technology. We explored how university-supported and external social media could support collaborative small group working on our new undergraduate medical curriculum. We made available a curation platform (Scoop.it) and a wiki within our virtual learning environment as part of year 1 Case-Based Learning, and did not discourage the use of other tools such as Facebook. We undertook student surveys to capture perceptions of the tools and information on how they were used, and employed software user metrics to explore the extent to which they were used during the year. Student groups developed a preferred way of working early in the course. Most groups used Facebook to facilitate communication within the group, and to host documents and notes. There were more barriers to using the wiki and curation platform, although some groups did make extensive use of them. Staff engagement was variable, with some tutors reviewing the content posted on the wiki and curation platform in face-to-face sessions, but not outside these times. A small number of staff posted resources and reviewed student posts on the curation platform. Optimum use of these tools depends on sufficient training of both staff and students, and an opportunity to practice using them, with ongoing support. The platforms can all support collaborative learning, and may help develop digital literacy, critical appraisal skills, and awareness of wider health issues in society.